Recent advances in single-cell sequencing have begun to reveal the transcriptional diversity in the CNS, including cell types expressing a number of S1P receptors. Our approach pairs extraction of cellular nuclei with single-cell sequencing using 10X Genomics to assess differential activation of individual cellular subpopulations in primary human astrocytes and post-mortem human MS brain samples. Extraction of nuclei for single-cell sequencing provides 2 main advantages: 1) Nuclei provide an instantaneous “snapshot” of cellular transcriptional state, avoiding artifacts generated from creating whole-cell suspensions from the brain and 2) Nuclei isolation provides an unbiased method to sample all cell types within CNS tissue, independent of cellular morphology. Effects of S1P receptor modulators in primary human astrocytes are also being assessed.